Results 21 to 30 of about 7,373,821 (305)
Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics [PDF]
, 2007 Upon HIV transmission, some patients develop AIDS in only a few months, while others remain disease free for 20 or more years. This variation in the rate of disease progression is poorly understood and has been attributed to host genetics, host immune ...Pybus, OG, Drummond Alexei J, Lemey, P, Drummond, AJ, Kosakovsky Pond, Sergei L., Shapiro, B, Alexei J. Drummond, Pond, Sergei L. Kosakovsky|, Shapiro Beth, Helena Barroso, Kosakovsky Pond Sergei L, Pybus Oliver G, Beth Shapiro, Rambaut, A, Barroso, H, Philippe Lemey, Shapiro, Beth, Sergei L Kosakovsky Pond, Alexei J Drummond, Nuno Taveira, Rambaut Andrew, Drummond, Alexei J., Rambaut, Andrew, Kosakovsky Pond, SL, Pybus, Oliver G., Lemey Philippe, Andrew Rambaut, Lemey, Philippe, Barroso, Helena, Sergei L. Kosakovsky Pond, Oliver G. Pybus, Taveira Nuno, Oliver G Pybus, Barroso Helena, Pond, Sergei L. Kosakovsky, Taveira, N, Pond, SLK, Taveira, Nuno +37 morecore +1 more sourceMachine Learning Use for Prognostic Purposes in Multiple Sclerosis
Life, 2021 The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secondarily progressive form over an extremely variable period, depending on many factors, each with a subtle influence. To date, no prognostic factors or risk Ruggiero Seccia, Silvia Romano, Marco Salvetti, Andrea Crisanti, Laura Palagi, Francesca Grassi +5 moredoaj +1 more sourceProgression of glomerular diseases [PDF]
Journal of Internal Medicine, 1994 Abstract. The nature and slope of progression of glomerular diseases is the subject of considerable discussion. The use of renal biopsies has been accompanied by considerable improvement in the classification of glomerular disease. However, the clinical and histological tools available to assess prognosis in individual patients lack accuracy ...E P, Peten, L J, Strikeropenaire +2 more sourcesUtility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital
Frontiers in Immunology, 2023 PurposeThis study was performed to determine the clinical biomarkers and cytokines that may be associated with disease progression and in-hospital mortality in a cohort of hospitalized patients with RT-PCR confirmed moderate to severe COVID-19 infection ...Felix Eduardo R. Punzalan, Felix Eduardo R. Punzalan, Jaime Alfonso M. Aherrera, Jaime Alfonso M. Aherrera, Sheriah Laine M. de Paz-Silava, Alric V. Mondragon, Alric V. Mondragon, Anna Flor G. Malundo, Anna Flor G. Malundo, Joanne Jennifer E. Tan, Joanne Jennifer E. Tan, Ourlad Alzeus G. Tantengco, Ourlad Alzeus G. Tantengco, Elgin Paul B. Quebral, Mary Nadine Alessandra R. Uy, Mary Nadine Alessandra R. Uy, Ryan C. V. Lintao, Jared Gabriel L. Dela Rosa, Maria Elizabeth P. Mercado, Krisha Camille Avenilla, Jonnel B. Poblete, Albert B. Albay, Albert B. Albay, Aileen S. David-Wang, Aileen S. David-Wang, Marissa M. Alejandria, Marissa M. Alejandria, Marissa M. Alejandria +27 moredoaj +1 more sourceProlonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC) [PDF]
, 2005 Background: The aim of this retrospective analysis was to evaluate the impact of trastuzumab-based regimens on the survival of patients with HER2-overexpressing metastatic breast cancer (MBC).Heinrich, B., Stemmler, H. J., Kahlert, S., Heinemann, Volker, Siekiera, W., Untch, M. +5 morecore +1 more sourceCFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. [PDF]
, 2009 Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been Weber, Bernhard H. F., Fleckenstein, Monika, Frank G Holz, Weber, B. H., Hendrik P N Scholl, Scholl, Hendrik P. N., Tim Becker, Ulrich Mansmann, Weinberger Andreas W. A., Schmitz-Valckenberg Steffen, Mackensen, F., Herold Christine, Holz, Frank G, Scholl Hendrik P. N., Weber, Bernhard H F, Andreas Mössner, Keilhauer, Claudia N, Scholl, Hendrik P N, Fritsche, Lars G., Steffen Schmitz-Valckenberg, Schmitz-Valckenberg, S., Claudia N Keilhauer, Weinberger, A. W., Fritsche, Lars G, Weinberger, Andreas W. A., Pauleikhoff, D., Becker, T., Andreas W A Weinberger, Adrion, Christine, Mansmann Ulrich, Weber Bernhard H. F., Becker Tim, Göbel, Arno, Mackensen Friederike, Holz, F. G., Monika Fleckenstein, Göbel, A., Adrion Christine, Holz Frank G., Scholl, H. P., Friederike Mackensen, Mackensen, Friederike, Mansmann, Ulrich, Göbel Arno, Becker, Tim, Fleckenstein Monika, Mössner, Andreas, Lars G Fritsche, Fritsche Lars G., Keilhauer Claudia N., Schmitz-Valckenberg, Steffen, Fritsche, L. G., Herold, Christine, Arno Göbel, Daniel Pauleikhoff, Weinberger, Andreas, Christine Herold, Mansmann, U., Christine Adrion, Bernhard H F Weber, Mössner, A., Pauleikhoff, Daniel, Keilhauer, C. N., Herold, C., Holz, Frank G., Adrion, C., Mößner Andreas, Pauleikhoff Daniel, Fleckenstein, M. +68 morecore +2 more sourcesLandscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data
Frontiers in Pharmacology, 2022 The 21st Century Cures Act requires FDA to expand its use of real-world evidence (RWE) to support approval of previously approved drugs for new disease indications and post-marketing study requirements.Jeffrey S. Barrett, Megan Cala Pane, Timothy Knab, William Roddy, Jack Beusmans, Eric Jordie, Kanwaljit Singh, Jonathan Michael Davis, Klaus Romero, Michael Padula, Bernard Thebaud, Mark Turner +11 moredoaj +1 more sourceA systematic review of biomarkers for disease progression in Alzheimer's disease [PDF]
, 2014 Peer ...Wright, David E, McGhee, David J. M., Carl E Counsell, John P. Zajicek, Counsell Carl E., Paul A Thompson, Zajicek, John P, McGhee, Djm, David E Wright, Zajicek John P., Paul A. Thompson (523911), Thompson Paul A., Zajicek, J. P., Thompson, Paul A., David J. M. Mcghee, McGhee, David J.M., Ritchie, C. W., McGhee David J. M., Wright, D. E., McGhee, David J M, Wright David E., David J. M. McGhee (523909), Ritchie, Craig W, Carl E. Counsell (523914), Thompson, P. A.; id_orcid, Wright, David E., David E. Wright (523912), Paul A. Thompson, Thompson, Paul A, David E. Wright, Ritchie, Craig W., McGhee, David, Carl E. Counsell, John P. Zajicek (523913), Thompson, P. A., Craig W. Ritchie (523910), Craig W Ritchie, John P Zajicek, Counsell, Carl E, Zajicek, John P., David J M McGhee, Craig W. Ritchie, Thompson, Paul A.; id_orcid, Counsell, Carl E., Ritchie Craig W. +44 morecore +1 more sourceProgression of Liver Diseases [PDF]
Hepatitis Monthly, 2012 Dear Editor, To date, the knowledge on the natural history of HCV infection and the risk factors associated with progression of liver disease in children is limited. Progressive liver disease, including hepatocellular carcinoma, is rare but has been reported [1].openaire +2 more sourcesA high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020 Introduction The progression rate of Alzheimer's disease (AD) varies and might be affected by the triggering receptor expressed on myeloid cells (TREM2) activity.Trine Holt Edwin, Kristi Henjum, Lars N.G. Nilsson, Leiv Otto Watne, Karin Persson, Rannveig Sakshaug Eldholm, Ingvild Saltvedt, Nathalie Bodd Halaas, Geir Selbæk, Knut Engedal, Bjørn Heine Strand, Anne‐Brita Knapskog +11 moredoaj +1 more source
